Biotech · Private company
Tceleron Therapeutics, Inc.
Track this companyFree. Adds Tceleron Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- TmPSMA-02Phase 2 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- AnakinraPhase 1 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- CART-PSMA-TGFβRDNPhase 1 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Metastatic Castration-resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)PHASE1_PHASE2 · TERMINATED · started Sep 6, 2022ClinicalTrials.gov NCT05489991 · fetched Nov 12, 2026
- A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate CancerPHASE1 · TERMINATED · started Nov 22, 2019ClinicalTrials.gov NCT04227275 · fetched Nov 12, 2026